897619480	897619480	CD	B-NP	O
|	|	NNP	I-NP	O
ESHMC	ESHMC	NNP	I-NP	O
|	|	VBD	B-VP	O
74401568	74401568	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1866834	1866834	CD	B-NP	O
|	|	CC	I-NP	O
7/24/2006	7/24/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Coronary	Coronary	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
414.01	414.01	CD	B-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/5/2006	6/5/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/23/2006	10/23/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MCLYMAN	MCLYMAN	NN	B-NP	O
,	,	,	O	O
ANDREAS	ANDREAS	NN	B-NP	O
741-42-04-3	741-42-04-3	CD	I-NP	O
Pervgle	Pervgle	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/19/06	10/19/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FERGE	FERGE	NNP	B-NP	O
,	,	,	O	O
WALLY	WALLY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TESSALON	TESSALON	NNP	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/2	8/2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CODEINE	CODEINE	NNP	I-NP	O
PHOSPHATE	PHOSPHATE	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q3H	Q3H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sedated	sedate	VBN	B-VP	O
,	,	,	O	O
rr	rr	NN	B-NP	O
<	<	SYM	I-NP	O
12	12	CD	I-NP	O
DEXTROMETHORPHAN	DEXTROMETHORPHAN	NN	I-NP	O
HBR	HBR	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sedated	sedate	VBN	B-VP	O
,	,	,	O	O
rr	rr	NN	B-NP	O
<	<	SYM	I-NP	O
12	12	CD	I-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
ZETIA	ZETIA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EZETIMIBE	EZETIMIBE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	O
if	if	IN	B-SBAR	O
BG	BG	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
POTASSIUM	POTASSIUM	NN	I-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NNP	B-NP	O
***	***	NNP	I-NP	O
LOW	LOW	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
REPLACEMENT	REPLACEMENT	NNP	I-NP	O
SCALE	SCALE	NNP	I-NP	O
ORAL	ORAL	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Frequency	Frequency	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
KCL	KCL	NN	I-NP	B-protein
Immediate	Immediate	JJ	I-NP	I-protein
Release	Release	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
sustained-release	sustained-release	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
scale	scale	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Replace	Replace	NN	B-NP	O
KCL	KCL	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
lab	lab	NN	B-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
SMH	SMH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4oz	4oz	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
ordered	order	VBN	I-VP	O
and	and	CC	O	O
checked	check	VBN	B-VP	O
daily	daily	RB	B-ADVP	O
while	while	IN	B-SBAR	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
K-scale	K-scale	NN	I-NP	O
.	.	.	O	O

6.K-scale	6.K-scale	NN	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
on	on	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
:	:	:	O	O
*	*	SYM	B-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
*	*	SYM	B-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Hold	Hold	NN	B-NP	O
scale	scale	NN	I-NP	O
and	and	CC	O	O
contact	contact	NN	B-NP	O
MD	MD	NN	I-NP	O
if	if	IN	B-SBAR	O
SCr	SCr	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
3.1	3.1	CD	I-NP	O
then	then	RB	B-ADVP	O
call	call	VB	B-VP	O
H.O.	H.O.	NNP	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
3.1-3	3.1-3	CD	B-NP	O
.3	.3	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
orally	orally	RB	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
20	20	CD	B-NP	O
meq	meq	NN	I-NP	O
orally	orally	RB	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	B-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
3.4-3	3.4-3	CD	B-NP	O
.6	.6	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
orally	orally	RB	B-VP	O
Recheck	Recheck	VB	I-VP	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	O	O
Level	Level	NNP	B-NP	O
is	be	VBZ	B-VP	O
3.7-4	3.7-4	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
orally	orally	RB	B-ADVP	O
Recheck	Recheck	VB	B-VP	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	O	O
Level	Level	NNP	B-NP	O
is	be	VBZ	B-VP	O
4.1-5	4.1-5	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NN	B-NP	O
NOT	NOT	NN	I-NP	O
administer	administer	NN	I-NP	O
KCL	KCL	NN	I-NP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	B-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
in	in	IN	B-PP	O
QAM	QAM	NN	B-NP	B-protein
If	If	IN	B-SBAR	I-protein
K	K	NN	B-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
5.0	5.0	CD	B-NP	O
then	then	RB	B-ADVP	O
call	call	VB	B-VP	O
H.O.	H.O.	NNP	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
by	by	IN	B-PP	O
MERLING	MERLING	NNP	B-NP	O
,	,	,	O	O
SHIRLEY	SHIRLEY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIOVAN	DIOVAN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
905615702	905615702	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
GLUCONATE	GLUCONATE	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
orally	orally	RB	B-ADVP	O
-RRB-	-RRB-	HYPH	B-NP	O
DAILY	DAILY	NN	I-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
Mg-scales	Mg-scale	NNS	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
doses	dose	NNS	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
individualized	individualize	VBN	I-VP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
:	:	:	O	O
-	-	:	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
-	-	:	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Call	Call	NN	B-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
0.8	0.8	CD	I-NP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
1.0-1	1.0-1	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
1.6-1	1.6-1	CD	B-NP	O
.9	.9	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
2.0-2	2.0-2	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Do	Do	VBP	B-VP	O
Not	Not	RB	I-VP	O
administer	administer	VB	I-VP	O
Mg	Mg	NN	B-NP	O
Gluconate	Gluconate	NN	I-NP	O
Call	Call	NN	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.5	2.5	CD	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
5-10	5-10	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Pain	Pain	NN	I-NP	I-protein
PINDOLOL	PINDOLOL	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ZOCOR	ZOCOR	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIOVAN	DIOVAN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/20	1/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
by	by	IN	B-PP	O
MCCALEBB	MCCALEBB	NNP	B-NP	O
,	,	,	O	O
TYRONE	TYRONE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-PP	O
tolerated	tolerate	VBN	B-NP	O
Lift	Lift	NN	I-NP	O
restrictions	restriction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
lift	lift	VB	I-VP	O
greater	great	JJR	B-NP	O
then	then	RB	B-ADVP	O
15	15	CD	B-NP	O
pounds	pound	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Muehl	Muehl	NNP	I-NP	O
He	He	NNP	I-NP	O
will	will	MD	B-VP	O
arrange	arrange	VB	I-VP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Elective	Elective	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
PCI	PCI	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Coronary	Coronary	NNP	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
414.01	414.01	CD	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
stent	stent	NN	B-NP	O
to	to	TO	B-PP	O
old	old	JJ	B-NP	O
CABG	CABG	NN	I-NP	O
vessel	vessel	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CXR	CXR	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Elective	Elective	JJ	B-NP	O
Cardiac	Cardiac	JJ	I-NP	O
Cath	Cath	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
yo	yo	NN	I-NP	O
female	female	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
CABG	CABG	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
,	,	,	O	O
DM	DM	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
after	after	IN	B-PP	O
elective	elective	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
s/p	s/p	NN	I-NP	O
abnormal	abnormal	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Cath	Cath	NNP	B-NP	O
showed	show	VBD	B-VP	O
impaired	impaired	JJ	B-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
posterolateral	posterolateral	JJ	I-NP	O
zones	zone	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
obstructive	obstructive	JJ	B-NP	O
degenerative	degenerative	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SVGs	SVG	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
and	and	CC	I-NP	O
LCF-OM	LCF-OM	NN	I-NP	B-protein
.	.	.	O	O

Stent	Stent	NN	B-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	O
graft	graft	NN	I-NP	O
though	though	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
calcification	calcification	NN	I-NP	O
and	and	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
obtaining	obtain	VBG	B-VP	O
full	full	JJ	B-NP	O
stent	stent	JJ	I-NP	O
expansion	expansion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
stent	stent	JJ	I-NP	O
deployment	deployment	NN	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
poor	poor	JJ	B-NP	O
reflow	reflow	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
mild	mild	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
hemodynamic	hemodynamic	JJ	B-NP	O
embarrassment	embarrassment	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
without	without	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
call	call	NN	B-NP	O
out	out	RP	B-PRT	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
jaw	jaw	NN	B-NP	O
sensation	sensation	NN	I-NP	O
,	,	,	O	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
upset	upset	VBN	I-VP	O
by	by	IN	B-PP	O
turn	turn	NN	B-NP	O
of	of	IN	B-PP	O
events	event	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
calmed	calm	VBN	I-VP	O
by	by	IN	B-PP	O
staff	staff	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
then	then	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Demora	Demora	NNP	I-NP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
Seygo	Seygo	NNP	I-NP	O
No	No	NNP	I-NP	O
Wood	Wood	NNP	I-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
DMII	DMII	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
,	,	,	O	O
Cirrhosis	Cirrhosis	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
1997	1997	CD	I-NP	O
s/p	s/p	NN	I-NP	O
AAA	AAA	NN	I-NP	O
repair	repair	NN	I-NP	O
1996	1996	CD	I-NP	O
s/p	s/p	NN	I-NP	O
aorto-fem	aorto-fem	NN	I-NP	O
bypass	bypass	RB	B-NP	O
1996	1996	CD	I-NP	O
s/p	s/p	NN	I-NP	O
TAHBSO	TAHBSO	NN	I-NP	O
Meds	Meds	NNP	I-NP	O
Lantus	Lantus	NNP	I-NP	O
40u	40u	NNP	I-NP	O
qd	qd	VBD	B-VP	O
Estradiol	Estradiol	NNP	B-NP	O
0.05	0.05	CD	I-NP	O
Diltiazem	Diltiazem	NNP	I-NP	O
180	180	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
HCTZ	HCTZ	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Zetia	Zetia	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
Diovan	Diovan	NNP	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
ASA	ASA	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
MV	MV	NN	I-NP	O
Meds	Med	NNS	I-NP	O
in	in	IN	B-PP	O
CCU	CCU	NN	B-NP	B-protein
ASA	ASA	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
Lantus	Lantus	NNP	I-NP	I-protein
20u	20u	NNP	I-NP	I-protein
qd	qd	VBD	B-VP	I-protein
Plavix	Plavix	NNP	B-NP	I-protein
75	75	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
Zetia	Zetia	NNP	B-NP	I-protein
10mg	10mg	CD	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
Famotidine	Famotidine	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
Pindolol	Pindolol	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Lovenox	Lovenox	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
sc	sc	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
nicotine	nicotine	NN	I-NP	I-protein
patch	patch	NN	I-NP	I-protein
MgSO4	MgSO4	NN	I-NP	I-protein
SS	SS	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SS	SS	NNP	I-NP	O
Novolog	Novolog	NNP	I-NP	O
SS	SS	NNP	I-NP	O
Pt	Pt	NNP	I-NP	O
Status	Status	NNP	I-NP	O
Vitals	Vitals	NNP	I-NP	O
Gen	Gen	NNP	I-NP	O
-	-	HYPH	O	O
Awake	Awake	NNP	B-NP	O
,	,	,	O	O
Alert	Alert	NNP	B-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
-	-	HYPH	B-NP	O
JVP	JVP	NN	I-NP	B-protein
6	6	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
Chest	Chest	NNP	B-NP	O
-	-	HYPH	I-NP	O
CTAB	CTAB	NN	I-NP	B-protein
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
rhonchi/wheezes	rhonchi/wheez	NNS	I-NP	O
R	R	NN	I-NP	O
>	>	SYM	O	O
L	L	NN	B-NP	B-protein
CV	CV	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
RRR	RRR	NN	I-NP	B-protein
,	,	,	O	O
Nml	Nml	NN	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
SEM	SEM	NNP	I-NP	O
at	at	IN	B-PP	O
LLSB	LLSB	NNP	B-NP	O
Abd	Abd	NNP	I-NP	O
-	-	HYPH	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
organomegaly	organomegaly	RB	B-NP	O
Extr	Extr	NN	I-NP	O
-	-	HYPH	B-NP	O
L	L	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
bruit	bruit	NN	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-DNA
cath	cath	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
oozing	oozing	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
hematoma	hematoma	NN	B-NP	O
,	,	,	O	O
ecchymosis	ecchymosis	NN	B-NP	O
present	present	JJ	I-NP	O
Studies	Study	NNS	I-NP	O
CAth	CAth	NNP	B-NP	O
-	-	HYPH	I-NP	O
Right	Right	NNP	I-NP	O
Dominant	Dominant	NNP	I-NP	O
Circulation	Circulation	NNP	I-NP	O
Left	Left	NNP	I-NP	O
Main	Main	NNP	I-NP	O
Coronary	Coronary	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
No	No	NNP	I-NP	O
significant	significant	JJ	I-NP	O
LM	LM	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
identified	identify	VBD	B-VP	O
Left	Left	NNP	B-NP	O
Anterior	Anterior	NNP	I-NP	O
Descending	Descending	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
LAD	LAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
LAD	LAD	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ostial	Ostial	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
Left	Left	NNP	I-NP	O
Circumflex	Circumflex	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
CX	CX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
Right	Right	NNP	I-NP	O
Coronary	Coronary	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
RCA	RCA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
RT	RT	NN	I-NP	O
PDA	PDA	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Mid	Mid	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
Coronary	Coronary	NNP	I-NP	O
Artery	Artery	NNP	I-NP	O
Bypass	Bypass	NNP	I-NP	O
Grafts	Grafts	NNP	I-NP	O
:	:	:	O	O
SVG	SVG	NN	B-NP	O
Graft	Graft	NN	I-NP	O
to	to	TO	B-PP	O
RT	RT	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
Mid	Mid	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
STENT	STENT	NN	I-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
LIMA	LIMA	NN	I-NP	O
Graft	Graft	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
SVG	SVG	NN	I-NP	O
Graft	Graft	NN	I-NP	O
to	to	TO	B-PP	O
MARG1	MARG1	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
Ostial	Ostial	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
SVG	SVG	NN	I-NP	O
Graft	Graft	NN	I-NP	O
to	to	TO	B-PP	O
MARG1	MARG1	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Discrete	Discrete	NNP	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
Collateral	Collateral	JJ	I-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
LAD	LAD	NN	B-NP	B-protein
to	to	TO	B-PP	O
RT	RT	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
A/P	A/P	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
Ischemia	Ischemia	NN	I-NP	O
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	B-protein
had	have	VBD	B-VP	I-protein
elective	elective	JJ	B-NP	I-protein
PCI	PCI	NN	I-NP	I-protein
on	on	IN	B-PP	O
9/6/06	9/6/06	CD	B-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
experience	experience	NN	B-NP	O
jaw	jaw	NN	I-NP	O
sensations	sensation	NNS	I-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
post	post	NN	I-NP	O
procedure	procedure	NN	I-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
as	as	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
periprocedure	periprocedure	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
previous	previous	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
angina	angina	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
release	release	NN	B-NP	O
from	from	IN	B-PP	O
CCU	CCU	NN	B-NP	B-DNA
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
current	current	JJ	I-NP	O
chest	chest	NN	I-NP	O
or	or	CC	I-NP	O
jaw	jaw	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Continuing	Continue	VBG	B-VP	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
zetia	zetia	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
Integrelin	Integrelin	NN	I-NP	B-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
-	-	HYPH	I-NP	O
PT	PT	NN	I-NP	O
has	have	VBZ	B-VP	O
preserved	preserve	VBN	I-VP	O
fxn	fxn	NN	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
low	low	JJ	I-NP	O
normal	normal	JJ	I-NP	O
,	,	,	I-NP	O
pt	pt	NN	I-NP	O
euvolemic	euvolemic	JJ	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
-	-	HYPH	I-NP	O
NSR	NSR	NN	I-NP	B-protein
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
will	will	MD	B-VP	O
d/c	d/c	VB	I-VP	O
on	on	IN	B-PP	O
Betablocker	Betablocker	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
cough	cough	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
Post	Post	VB	I-VP	O
nasal	nasal	JJ	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
antihistamine	antihistamine	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
USOH	USOH	NN	B-NP	O
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
.	.	.	O	O

DID	DID	NN	B-NP	O
NOT	NOT	NN	I-NP	O
GIVE	GIVE	NN	I-NP	O
ANTIHISTAMINES	ANTIHISTAMINES	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
-	-	HYPH	I-NP	O
NO	NO	NN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
renal	renal	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
DMII	DMII	NN	I-NP	B-protein
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
SS	SS	NNP	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

FS	FS	NNP	B-NP	O
Glu	Glu	NNP	I-NP	O
monitored	monitor	VBD	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
adjustment	adjustment	NN	I-NP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
send	send	VB	I-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-protein
doses	dose	NNS	I-NP	I-protein
o	o	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	O
had	have	VBD	B-VP	O
cath	cath	NN	B-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
oozing	oozing	NN	I-NP	O
from	from	IN	B-PP	O
site	site	NN	B-NP	O
in	in	IN	B-PP	O
groin	groin	NN	B-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	B-protein
was	be	VBD	B-VP	O
stable	stable	JJ	B-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
Anticoagulation	Anticoagulation	NNP	B-NP	O
stopped	stop	VBD	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
including	include	VBG	B-PP	O
plavix	plavix	NN	B-NP	O
and	and	CC	I-NP	O
ASA	ASA	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
return	return	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
fever	fever	NN	B-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
medicines	medicine	NNS	B-NP	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
limit	limit	NN	I-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
day	day	NN	I-NP	O
to	to	TO	B-PP	O
non-strenuous	non-strenuous	JJ	B-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
make	make	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appts	appt	NNS	B-NP	O
.	.	.	O	O

with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
groin	groin	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
evaluate	evaluate	VB	B-VP	O
for	for	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
or	or	CC	I-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
Hct	Hct	NN	B-NP	B-protein
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
blood	blood	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TRANER	TRANER	NN	B-NP	O
,	,	,	O	O
BLAINE	BLAINE	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VI7	VI7	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/19/06	10/19/06	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
01	01	CD	B-NP	O
PM	PM	NN	I-NP	O
REVIEWED	REVIEWED	NN	I-NP	O
BY	BY	NN	I-NP	O
:	:	:	O	O
ELLERBECK	ELLERBECK	NNP	B-NP	O
,	,	,	O	O
JAIME	JAIME	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
******	******	NNP	I-NP	O
END	END	NNP	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NNP	B-NP	O
ORDERS	ORDERS	NNP	I-NP	O
******	******	SYM	B-NP	O

